Skip to main content
. 2021 Oct 18;5:101–111. doi: 10.1016/j.jdin.2021.09.006

Table I.

Determining patient profile—detailed considerations and discussion points

Consider
  • Acne location
    • Facial vs truncal: assess independently (13/13)
  • Presence/risk of acne-induced scarring (13/13)

  • Family history
    • Patients with a family history of acne may be at increased risk of sequelae or uncontrolled disease
  • Skin phototype
    • For example, acne-induced macular hyperpigmentation in patients with darker skin phototypes (Fitzpatrick scale IV-VI) (13/13)
  • Duration of acne

  • Length of previously unsuccessful treatment

  • Socioeconomic status

  • Parent/child dynamic


Discuss
  • History taking
    • Age and duration of acne
    • Acne location
    • Current acne severity vs “average day”
    • Prior and current treatments and the length of use
    • Prior adverse effects or tolerability issues
    • Level of discomfort/burden/quality of life issues
    • Menstrual cycle irregularities
    • Menstrual flares
    • Signs of hyperandrogenism
    • Family history of acne (13/13) and sequelae
    • Lifestyle triggers
    • Allergies
    • Comorbidities and concomitant medications
    • Use of cosmetics, moisturizers, hair products, and sunscreen (12/13)
    • Knowledge of acne pathogenesis
    • Whey protein use
    • Supplement use
    • Previous endocrinological workup

Indicates topics that were voted on via the Delphi process (Comprehensive list of statements available as Supplementary Material via Mendeley at https://data.mendeley.com/datasets/fy6mnvt7t7/1).